Guillaume Lingas
Paris, 75018, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.
Journal: Antiviral research
Published: January 27, 2026
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.
Journal: The Journal of infectious diseases
Published: September 09, 2025
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.
Journal: The Journal of antimicrobial chemotherapy
Published: July 10, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 05, 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.
Journal: Clinical pharmacology and therapeutics
Published: June 13, 2023
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
Journal: Journal of medical virology
Published: April 19, 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 15, 2023
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Journal: Nature communications
Published: March 17, 2022
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
Journal: The Journal of antimicrobial chemotherapy
Published: November 26, 2021
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 04, 2021
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Journal: Nature communications
Published: July 17, 2020
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.
Journal: PLoS computational biology
Published: April 09, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026